EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Deubiquitinases as Regulators and Therapeutic Targets in Vascular Diseases

Zi-Kun Lin iD, Lei Wang iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27188350 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Zi-Kun Lin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, Beijing Key Laboratory of Environment and Aging, School of Public Health, Capital Medical University, Beiji…. Hauptthemen laut MEDLINE: Vascular Diseases, Deubiquitinating Enzymes. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Center for Chronic and Noncommunicable Disease Control and Prevention, National Natural Science Foundation of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ubiquitination and deubiquitination are dynamic post-translational regulatory processes that control protein stability and signaling. Deubiquitinases (DUBs), which remove ubiquitin chains from target proteins, have emerged as important regulators of vascular homeostasis and disease. In this review, we summarize recent progress in defining the roles of DUBs in major vascular pathologies, including vascular inflammation, remodeling, neointimal formation, angiogenesis, endothelial barrier dysfunction, thrombosis, and fibrosis. Accumulating evidence indicates that distinct DUBs act in a cell type- and context-dependent manner in endothelial cells, vascular smooth muscle cells, immune cells, and fibroblasts, contributing to vascular diseases such as aortic aneurysm, atherosclerosis, pulmonary hypertension, ischemic stroke, and intimal hyperplasia. These findings support DUBs as key regulatory nodes integrating ubiquitin signaling with inflammatory and stress-response pathways in the vasculature. In parallel, efforts to pharmacologically modulate DUB activity have led to the development of selective inhibitors and activators, although challenges remain in achieving substrate specificity and tissue selectivity. Overall, DUBs represent promising therapeutic targets for vascular disease, and future studies should focus on defining disease-specific DUB–substrate networks and developing context-dependent strategies for precise vascular intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular DiseasesDeubiquitinating EnzymesHumansAnimalsMolecular Targeted TherapyUbiquitinationSignal Transduction

Stichwörter der Autor:innen

angiogenesisdeubiquitinases (DUBs)therapeutic targetsvascular diseasesvascular inflammationvascular remodeling

Substanzen

Deubiquitinating Enzymes

Autor:innen und Institutionen

  • Department of Nutrition and Food Hygiene, Beijing Key Laboratory of Environment and Aging, School of Public Health, Capital Medical University, Beijing 100069, China.
  • The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing 100029, China.
  • School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.

ORCID-Profile: Zi-Kun Lin, Lei Wang

Förderung

  • National Center for Chronic and Noncommunicable Disease Control and Prevention
  • National Natural Science Foundation of China
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project

Zitieren

APA

Lin, Z. K., & Wang, L. (2026). Deubiquitinases as Regulators and Therapeutic Targets in Vascular Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188350

Vancouver

Lin ZK, Wang L. Deubiquitinases as Regulators and Therapeutic Targets in Vascular Diseases. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188350

BibTeX
@article{Lin2026,
  author = {Lin, Zi-Kun and Wang, Lei},
  title = {Deubiquitinases as Regulators and Therapeutic Targets in Vascular Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27188350}
}
Kostenlos starten →